In breast cancer cell line T-47D ER antagonist tamoxifen inhibits TRPV6 channel function thereby impairing cell viability35, but subsequent studies using TRPV6-transfected MCF-7 and MDA-MB231 cells found that the effect of tamoxifen is ER independent18. Here, TRPV6 is linked to breast cancer.